CysLT1 Antagonist Q8

Based on 14 reference(s) in Google Scholar 8 10 14

Axon 2738

CAS [1541762-55-3]

MF C17H14ClNO2
MW 299.75

  • Purity: 99%
  • Soluble in DMSO

CysLT1 Antagonist Q8


CysLT1 antagonist Q8 inhibits developmental angiogenesis in transgenic fluorescent zebrafish, and inhibits human microvascular endothelial cell (HMEC-1) proliferation, tubule formation, and migration. CysLT1 antagonist Q8 elicits antiangiogenic effects in a VEGF-independent in vitro model of angiogenesis and exerts an additive antiangiogenic response with the anti-VEGF biologic bevacizumab.

KEYWORDS: CysLT1 Antagonist Q8 | supplier | CysLT1 antagonist | CAS [1541762-55-3] | [1541762-52-0] | Cysteinyl leukotrienes | CysLT | Antagonist | Receptors | Angiogenesis | Antiangiogenic

Size Unit Price Stock
10 mg €95.00 In Stock
50 mg €305.00 In Stock
Need more? Bulk Inquiry

The purity of Axon Ligands™ is confirmed by HPLC-MS, 1H-NMR and/or microanalysis. Analytical data are available upon request.

Caution: Axon Ligands™ are not fully tested. They are for research purposes only! Not for human consumption!

Please wait...